Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
932.10B
Market cap932.10B
Price-Earnings ratio
34.81
Price-Earnings ratio34.81
Dividend yield
0.64%
Dividend yield0.64%
Average volume
4.02M
Average volume4.02M
High today
$997.52
High today$997.52
Low today
$962.97
Low today$962.97
Open price
$975.05
Open price$975.05
Volume
1.98M
Volume1.98M
52 Week high
$1,133.95
52 Week high$1,133.95
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

Eli Lilly(LLY) stock is priced at $989.76, giving the company a market capitalization of 932.1B. It carries a P/E multiple of 34.81 and pays a dividend yield of 64.4%.

On 2026-05-12, Eli Lilly(LLY) stock traded between a low of $962.97 and a high of $997.52. Shares are currently priced at $989.76, which is +2.8% above the low and -0.8% below the high.

The Eli Lilly(LLY)'s current trading volume is 1.98M, compared to an average daily volume of 4.02M.

In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.

In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.

LLY News

The Motley Fool 3h
Stock Market Today: Wegovy Data Targets Eli Lilly's Crown; Amazon Launches 30-Minute Delivery - The Motley Fool

...

Stock Market Today: Wegovy Data Targets Eli Lilly's Crown; Amazon Launches 30-Minute Delivery - The Motley Fool
TipRanks 3h
Eli Lilly Extends Tirzepatide Push With New Phase 4 Study in India

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper...

24/7 Wall St. 4h
Eli Lilly Price Prediction: This Is Where The Stock Will End This Year

The analyst who called NVIDIA in 2010 just named his top 10 stocks and Eli Lilly wasn't one of them. Get them here FREE . Lilly’s guidance raise and Foundayo’s...

Eli Lilly Price Prediction: This Is Where The Stock Will End This Year

Analyst ratings

85%

of 33 ratings
Buy
84.8%
Hold
12.1%
Sell
3%

More LLY News

Nasdaq 4h
The 3 Best S&P 500 Stocks to Buy Now

Key Points Amazon has proven to be indispensable for enterprise cloud services and everyday essentials for millions. Visa faces an enormous opportunity in pro...

The 3 Best S&P 500 Stocks to Buy Now
TipRanks 6h
Eli Lilly Invests Another $4.5 Billion in U.S. Manufacturing as Weight-Loss Drugs Takeoff

Pharmaceutical giant Eli Lilly (LLY) has announced an additional $4.5 billion investment across two of its three Indiana manufacturing sites as sales of its wei...

Benzinga 6h
Roche, Eli Lilly Alzheimer's Blood Test Cleared In Europe For Earlier Detection

Roche Wins CE Mark For Alzheimer's Blood Test Roche said the same high and low cutoff values can be applied across both primary and secondary care settings to h...

Roche, Eli Lilly Alzheimer's Blood Test Cleared In Europe For Earlier Detection
Investor's Business Daily 6h
Why This Novo Nordisk-Tied Telehealth Titan Just Went Into Free Fall

Eli Lilly's Retatrutide Is So Hot, The Unlaunched Weight-Loss Drug Is Already Getting Knocked Off 5/08/2026 Eli Lilly is just wrapping up trials of its retatru...

Why This Novo Nordisk-Tied Telehealth Titan Just Went Into Free Fall
Simply Wall St 8h
Eli Lilly Ulcerative Colitis Data Highlights Omvoh Durability And Valuation Upside

Eli Lilly (NYSE:LLY) reported new four year data for Omvoh (mirikizumab) in ulcerative colitis. The results show durable disease clearance in patients over an...

Eli Lilly Ulcerative Colitis Data Highlights Omvoh Durability And Valuation Upside
Barron's 1d
What’s Ailing the Biggest Healthcare ETF? Eli Lilly, GLP-1 Troubles Are a Start.

Biotech and Pharma What’s Ailing the Biggest Healthcare ETF? Eli Lilly, GLP-1 Troubles Are a Start. In this article ABBV Eli Lilly is trying to catch Novo Nordi...

What’s Ailing the Biggest Healthcare ETF? Eli Lilly, GLP-1 Troubles Are a Start.
The Motley Fool 1d
Income or Growth: Which Healthcare Stock Fits Your Portfolio Right Now?

Equity markets have been fairly volatile this year due to rising inflation, geopolitical tensions, and the possibility of a coming recession. However, stocks ha...

Income or Growth: Which Healthcare Stock Fits Your Portfolio Right Now?

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.